Published in Cancer Weekly, August 26th, 1996
Researchers have found that KS cells express extremely high levels of the interleukin 13 (IL-13) receptor.
Taking advantage of this finding, they created an immunotoxin that combines IL-13 with the cytopathic moiety of Pseudomonas endotoxin. This toxin selectively kills KS cells in vitro.
"IL-13 receptors on AIDS-KS tumors represent a novel plasma membrane protein for targeting with a potent cytotoxic agent such as Pseudomonas toxin-based chimeric protein," said Syed R. Husain of the U.S. Food and Drug Administration (FDA) Center for Biologics...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1996-08-26)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.